Review: long‐acting somatostatin analogues
- 1 June 1987
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 1 (3) , 191-200
- https://doi.org/10.1111/j.1365-2036.1987.tb00618.x
Abstract
SUMMARY: This article reviews the chemistry, actions and chemical applications of somatostatin and its analogues. At present, their gastroenterological use should be considered in patients with the carcinoid syndrome and functioning pancreatic endocrine tumours; in endocrinology there is interest in their use for the management of patients with resistant acromegaly. With these possible exceptions, somatostatin analogues should at present be used only in the context of clinical trials.Keywords
This publication has 43 references indexed in Scilit:
- Treatment of the Malignant Carcinoid SyndromeNew England Journal of Medicine, 1986
- REGRESSION OF LIVER METASTASES IN PATIENT WITH GASTRIN-SECRETING TUMOUR TREATED WITH SMS 201-995The Lancet, 1986
- Treatment of Inoperable Glucagonoma with the Long-Acting Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1986
- Chemistry and Pharmacology of SMS 201-995, a Long-Acting Octapeptide Analogue of SomatostatinScandinavian Journal of Gastroenterology, 1986
- Rapid Reversal of Carcinoid Crisis with a Somatostatin AnalogueNew England Journal of Medicine, 1985
- Treatment of patients with pancreatic endocrine tumours using a new long-acting somatostatin analogue symptomatic and peptide responses.Gut, 1985
- REGRESSION OF METASTATIC VIPOMA WITH SOMATOSTATIN ANALOGUE SMS 201-995The Lancet, 1985
- Effect of a Long-Acting Somatostatin Analogue (SMS 201–995) in a Patient with Pancreatic CholeraNew England Journal of Medicine, 1985
- SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged actionLife Sciences, 1982
- SUPPRESSION OF PANCREATIC ENDOCRINE TUMOUR SECRETION BY LONG-ACTING SOMATOSTATIN ANALOGUEThe Lancet, 1979